Does CABERGOLINE Cause Reversible cerebral vasoconstriction syndrome? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Reversible cerebral vasoconstriction syndrome have been filed in association with CABERGOLINE (Cabergoline). This represents 0.8% of all adverse event reports for CABERGOLINE.
17
Reports of Reversible cerebral vasoconstriction syndrome with CABERGOLINE
0.8%
of all CABERGOLINE reports
0
Deaths
15
Hospitalizations
How Dangerous Is Reversible cerebral vasoconstriction syndrome From CABERGOLINE?
Of the 17 reports, 15 (88.2%) required hospitalization, and 3 (17.6%) were considered life-threatening.
Is Reversible cerebral vasoconstriction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABERGOLINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does CABERGOLINE Cause?
Drug ineffective (249)
Headache (142)
Off label use (129)
Nausea (103)
Maternal exposure during pregnancy (100)
Dizziness (94)
Cerebrospinal fluid leakage (78)
Fatigue (71)
Malaise (64)
Condition aggravated (61)
What Other Drugs Cause Reversible cerebral vasoconstriction syndrome?
ESCITALOPRAM OXALATE (165)
FLUOXETINE (154)
TACROLIMUS (127)
METHYLPREDNISOLONE (119)
SUMATRIPTAN (105)
VENLAFAXINE (105)
DULOXETINE (102)
SERTRALINE (102)
MYCOPHENOLATE MOFETIL (68)
CITALOPRAM HYDROBROMIDE (64)
Which CABERGOLINE Alternatives Have Lower Reversible cerebral vasoconstriction syndrome Risk?
CABERGOLINE vs CABOTEGRAVIR
CABERGOLINE vs CABOTEGRAVIR\RILPIVIRINE
CABERGOLINE vs CABOZANTINIB
CABERGOLINE vs CABOZANTINIB S-MALATE
CABERGOLINE vs CAFFEINE